Available IPD datapackage for study 'A Multicentre, 12 Week Double Blind Placebo Controlled Randomized Study Of Etanercept On A Background Nsaid In The Treatment Of Adult Subjects With Non Radiographic Axial Spondyloarthritis With A 92 Week Open Label Extension'
收藏DataCite Commons2025-07-11 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00006829.1
下载链接
链接失效反馈官方服务：
资源简介：
This is a two part study. During period one there will be a comparison of Etanercept (ETN)
against a placebo with both arms maintaining the background anti inflammatory drug prescribed
by their Physician. The hypothesis is that Etanercept will be superior to the placebo arm as
determined by the proportion of subjects achieving Assessments in Ankylosing Spondylitis
(ASAS)40 improvement at 12 weeks. This will be followed by 92 weeks extension where everyone
in the trial receives Etanercept (ETN) and a background non steroidal anti inflammatory
drug(NSAID).
提供机构：
Vivli
创建时间：
2025-07-11
